	Association of week-12 HBsAg Decline with HBsAg Clearance in Patients with Hepatitis B-Related Cirrhosis Receiving Pegylated Interferon Combined with Nucleos(T)ide Analogue Therapy: A Retrospective Cohort Study. Int J Gen Med Yang WY, Lin Y, Lin C, Pan C, Ye YM. PMID: 42583160 [PubMed]
	Impact of structured exercise-based regimen on frailty in pediatric cirrhosis: A randomized controlled trial. J Pediatr Gastroenterol Nutr Yadav D, Benjamin J, Kumar R, Baweja S, Sood V, Lal BB, Khanna R, Alam S. PMID: 42581480 [PubMed - as supplied by publisher]
	Sanshimao Formula Improves Recurrence-Free Survival in Early and Intermediate Hepatocellular Carcinoma Patients with Cirrhosis: A Randomized Controlled Trial. J Integr Complement Med Xie W, Zhang X, Zhao J, Meng Y, Li X, Du J. PMID: 42578431 [PubMed - as supplied by publisher]
	Effect of an Integrated Exercise Training Program on Muscle Mass and Functional Capacity in Sarcopenic Patients With Decompensated Liver Cirrhosis. Cureus Patil RS, Devi PT, Dhaygude KS, Brahmadande JS. PMID: 42577566 [PubMed]
	Comparison of Palliative Care Access Between Patients With Liver Cirrhosis and Hepatocellular Carcinoma: Nationwide Population-Based Study. J Korean Med Sci Jang JS, Oh SN, Pak H. PMID: 42576718 [PubMed - indexed for MEDLINE]
	Management of Cirrhosis in Diabetes: A Pragmatic Approach to the Patient. J Clin Endocrinol Metab Kumar A, Basu R. PMID: 42576448 [PubMed - as supplied by publisher]
	What a Placebo Arm Measures: Biopsy Misclassification and Embedded Lifestyle Care in Pooled Cirrhosis Incidence for Fibrotic MASH. Dig Dis Sci Kalal CR, Poyekar S, Joshi H, Zanwar S, Mandot A, Gupta P. PMID: 42570999 [PubMed - as supplied by publisher]
	[Exocrine Pancreatic Insufficiency in Hepatic Cirrhosis: a Cross-Sectional Study]. Acta Gastroenterol Latinoam Henríquez Auba V, Hurtado C, Mancilla Asencio C, Herman P, Neman A, Berger Z. PMID: 42569772 [PubMed]
	The creatinine-to-albumin ratio as a prognostic indicator in critically ill patients with cirrhosis: A cohort study. Medicine (Baltimore) Ying Y, Ying Q, Jing L, Ying F, Lv L, Yang X. PMID: 42566587 [PubMed - indexed for MEDLINE]
	Sequential FIB-4-based testing limits detection of fibrotic MASLD despite optimized ELF thresholds. Hepatol Commun Allen AM, Bobek OJ, Canning RE, Eslami M, Benson J, Graham R, Venkatesh S, Yin M, Ehman RL, Ou FS. PMID: 42566274 [PubMed - indexed for MEDLINE]
	Effects of laparoscopic splenectomy and azygoportal disconnection on liver reserve function for cirrhosis patients: a 1-year prospective study. Surg Endosc Ding S, Zhou LX, Gao TM, Shi ZB, Chen C, Jin SJ, Zhang C, Zhou BH, Bai DS, Jiang GQ. PMID: 42566007 [PubMed - as supplied by publisher]
	Supra-hepatic gallbladder in cirrhosis presenting as a mimic of intra-abdominal fat necrosis: Diagnostic pitfalls and clinical implications. SA J Radiol Chawla S, Sureka B, Rodha MS. PMID: 42564431 [PubMed]
	Empagliflozin versus dapagliflozin in patients with liver cirrhosis: A comparative real-world study on hepatic decompensation. Hepatol Forum Ahmed H, Razzak IA, Abdulrazzak E, Gomaa S, Lauchner J. PMID: 42564337 [PubMed]
	Peritonitis due to brucellosis in a patient newly diagnosed with liver cirrhosis complicated by ascites: A case report and literature review. Hepatol Forum Ekici R, Filiz M, Onus S, Akcay AG, Bakir T, Buyukturan G, Aydin EG, Ekici M, Aydinli M, Ercin CN. PMID: 42564226 [PubMed]
	Embolization of spontaneous portosystemic shunts for refractory hepatic encephalopathy in cirrhosis patients:A meta-analysis. Hepatol Forum Patel P, Ebrahim M, Zaher E, Khataniar H, Loganathan P, Adler DG. PMID: 42564112 [PubMed]
	Contribution of p38 MAPK in liver fibrosis: An overview of mechanisms, signaling pathways, and therapeutic targets (Review). Int J Mol Med Yang X, Li H, Ye H, Wu T, Xu F, Hu C, Yu C, Ye P. PMID: 42563688 [PubMed - indexed for MEDLINE]
	Comment on "Predictors of in-hospital mortality among patients with cirrhosis and renal replacement therapy in the ICU: a retrospective cohort study". Clin Res Hepatol Gastroenterol Chen Y, Su Y, Li Y. PMID: 42551519 [PubMed - as supplied by publisher]
	Sodium Glucose Co-Transporter 2 Inhibitors Use in Diabetic Patients with Cirrhosis Improves Liver-related Outcomes and Survival. Clin Transl Gastroenterol Jalil S, Bari K, Mumtaz K, Ibrahim A, Bhatti TK, Pothuraju S, Adam M, Magon HS, Duong N, Kwo PY. PMID: 42561405 [PubMed - as supplied by publisher]
	Screening for Advanced Liver Fibrosis: Comparing Serum Indices With Elastography in a Nationally Representative U.S. Cohort. Mil Med Beltran TA, Rogers SM, Molina JN, Maldonado CJ, Berry-Cabán CS, Choi YS. PMID: 42560253 [PubMed - indexed for MEDLINE]
	Lasso Regression-based Model for Cross-Sectional Identification of Significant Hepatic Fibrosis in NAFLD LASSO-based identification of hepatic fibrosis in NAFLD. Biomed Environ Sci Deng W, Zhang YQ, Cao WH, Wang SJ, Wang SY, Zhang ZY, Li XX, Yao LM, Gao ZX, Wei X, Ma TY, Qiu DY, Hao HX, Xie Y, Li MH. PMID: 42559882 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 39084

Page 1 of 1955



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy